back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-01-13 16:07 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Hoffman, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$12,482
+11,666 vol $1.07 each |
38,334 | |
| Filed 2024-01-13 16:06 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Hoffman, Robert
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-12,482.62
-11,666 vol $1.07 each |
1,666 | |
| Filed 2023-11-18 15:22 Tx date 2023-11-15 |
$ATE
Antibe Therapeutics Inc. |
Hoffman, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,733
+1,667 vol $1.04 each |
26,668 | |
| Filed 2023-11-18 15:22 Tx date 2023-11-15 |
$ATE
Antibe Therapeutics Inc. |
Hoffman, Robert
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-1,733.68
-1,667 vol $1.04 each |
13,332 | |
| Filed 2023-09-15 18:26 Tx date 2023-09-12 |
$ATE
Antibe Therapeutics Inc. |
Hoffman, Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
20,000 | |
| Filed 2023-01-14 15:58 Tx date 2023-01-11 |
$ATE
Antibe Therapeutics Inc. |
Hoffman, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$6,883
+11,667 vol $0.59 each |
25,001 | |
| Filed 2023-01-14 15:57 Tx date 2023-01-11 |
$ATE
Antibe Therapeutics Inc. |
Hoffman, Robert
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-6,883.53
-11,667 vol $0.59 each |
14,999 | |
| Filed 2022-11-19 13:11 Tx date 2022-11-15 |
$ATE
Antibe Therapeutics Inc. |
Hoffman, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$800.16
+1,667 vol $0.48 each |
13,334 | |
| Filed 2022-11-19 13:08 Tx date 2022-11-15 |
$ATE
Antibe Therapeutics Inc. |
Hoffman, Robert
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-800.16
-1,667 vol $0.48 each |
26,666 | |
| Filed 2022-11-19 13:02 Tx date 2022-11-15 |
$ATE
Antibe Therapeutics Inc. |
Hoffman, Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,000 vol |
5,000 | |
| Filed 2022-11-19 13:01 Tx date 2020-11-24 |
$ATE
Antibe Therapeutics Inc. |
Hoffman, Robert
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-01-13 14:06 Tx date 2022-01-11 |
$ATE
Antibe Therapeutics Inc. |
Hoffman, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+11,667 vol |
11,667 | |
| Filed 2022-01-13 14:04 Tx date 2020-11-24 |
$ATE
Antibe Therapeutics Inc. |
Hoffman, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-01-13 14:03 Tx date 2022-01-11 |
$ATE
Antibe Therapeutics Inc. |
Hoffman, Robert
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-11,667 vol |
28,333 | |
| Filed 2021-11-19 20:27 Tx date 2021-11-15 |
$ATE
Antibe Therapeutics Inc. |
Hoffman, Robert
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+5,000 vol |
40,000 | |
| Filed 2021-01-15 18:37 Tx date 2021-01-11 |
$ATE
Antibe Therapeutics Inc. |
Hoffman, Robert
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+35,000 vol |
35,000 | |
| Filed 2021-01-15 18:36 Tx date 2020-11-24 |
$ATE
Antibe Therapeutics Inc. |
Hoffman, Robert
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|